Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

October edition of BITNews

28 April 201314 October 2010 by Karen Mobbs

October 2010 edition of BITNews

Categories 2010, ASX Announcements, Newsletters
Post navigation
Phase II HCV Clinical Trial Commenced
Presentation to Investors
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 7 January 2021        Legal Notices and Privacy